Journal of the American Chemical Society
Article
method could offer a general strategy for the rapid synthesis of
CF2H analogues of pharmaceutical agents. Therefore, we
performed a series of late-stage modifications on medicinally
relevant molecules (Figure 3). The xanthate esters of
derivatives of lonidamine, an antispermatogenic and anticancer
agent,32 as well as adapalene, a topical retinoid for the
treatment of acne,33 were converted to their CF2H analogues
(69 and 70) in 46% and 64% yield, respectively. The
difluoromethylation of a precursor to rosuvastatin, a medicine
used to lower cholesterol,34 allowed for the incorporation of a
CF2H group on the sterically hindered heterobenzylic position
of a pyrimidine ring in a 65% yield (71). The analogue of
rimonabant, an anorectic antiobesity drug,35 was converted to
the CF2H analogue in a 72% yield, with three aryl chloride
bonds remaining unaffected (72).
In addition, the CF2H analogue of the protected DOPA
(73), an amino acid made as part of the human biology and
used in the clinical treatment of Parkinson’s disease,36 could be
synthesized in an 85% yield from its xanthate ester.
Levothyroxine, one of the top-selling drugs for the treatment
of thyroid hormone deficiency and thyroid tumors,37 was
converted to its CF2H analogue (74) via the xanthate
intermediate in a 52% yield. It is worth noting that the
tolerance of multiple aryl iodides on electron-rich phenyl rings
further highlighted the mild conditions of this copper-catalyzed
protocol. Moreover, an analogue of lisdexamfetamine, one of
the most prescribed medications in the United States for
treating attention deficit hyperactivity disorder and binge
eating disorder,38 was converted to its CF2H analogue (75) in
a synthetically useful yield.
Finally, we aimed to synthesize the CF2H bioisostere of
ezetimibe, one of the top-selling pharmaceuticals to treat high
blood cholesterol.39 A main metabolic pathway of ezetimibe
involves the oxidation of its benzylic hydroxyl group to form
the ketone metabolite.40 We expected that the replacement of
the benzylic hydroxyl group with a CF2H group should block
such a metabolic pathway while partially retaining the original
hydrogen-bonding ability. To our delight, the xanthate ester of
the benzyl-protected ezetimibe was converted to the
difluoromethylated product (76) under the standard con-
ditions in a 50% yield. These examples further highlighted the
potential of this copper-catalyzed protocol for the rapid
synthesis of CF2H-containing pharmaceuticals.
Mechanistic Studies. Mechanistic experiments were
conducted to shed light on this deoxygenative difluoromethy-
lation reaction. The addition of a radical-trapping reagent
TEMPO (2 equiv) to the difluoromethylation of 14 led to a
suppression of the formation of 15, while the generation of an
aryl-TEMPO adduct (77) was detected by GC. 77 was also
formed when the reactions were conducted without the
xanthate esters, supporting the notion that aryl radicals were
formed in the reactions between aryl diazonium salts and
[Cu−CF2H] species (Figure 4A). In addition, to establish the
involvement of alkyl radicals in these reactions, we conducted
the difluoromethylation of a cyclopropyl-bearing substrate
(78). The difluoromethylation of this radical clock substrate
afforded the unrearranged product (79), along with the ring-
opened product (80), consistent with the hypothesis that
short-lived alkyl radicals were involved in the reactions (Figure
4B). More importantly, this result ruled out the alternative
pathway which involved the direct nucleophilic substitution of
a [CuI−CF2H] species with the xanthate ester via a SN2
mechanism.
Figure 4. Mechanistic studies supported the proposed aryl radical
activation mechanism.
Moreover, the proposed mechanism in Figure 2 was further
supported by the detection of the S-aryl dithiocarbonate side
product (81) in all the difluoromethylation reactions (Figure
4C). We were able to isolate this compound, the structure of
which was unambiguously confirmed by NMR. The isolation
of 81, together with the fact that no difluoromethylated
products were formed in the absence of diazonium salts,
supported the postulation that aryl radicals were the key to the
activation of xanthate esters.
CONCLUSION
■
The Barton-McCombie reaction has taught the synthetic
community that the formation of alkyl xanthate esters is an
efficient strategy for the activation of alcohols via radical
intermediates. However, the synthetic utility of xanthates has
been significantly limited to the deoxygenation reactions,
largely due to the lack of suitable activation modes that could
engage them in transition metal-catalyzed coupling reactions.
Due to the high reactivity of aryl radicals, they have been
widely used in organic synthesis as building blocks for the
installation of aryl groups. However, the synthetic utility of aryl
radicals as reagents for the activation of functional groups
remains an underexplored yet highly promising approach in
synthetic organic chemistry.
By tuning the electronic properties of aryl diazonium salts,
we disclose herein a unique aryl radical activation approach to
engage alcohol-derived xanthate esters in cross-coupling
reactions via copper catalysis, allowing for the discovery of
the first catalytic deoxygenative difluoromethylation reaction.
Mechanistic studies were consistent with an aryl radical
activation pathway. Despite the current limitations and the
additional work required to extend the scope of alcohols
beyond ones bearing radical stabilizing groups, we expect that
this protocol could find its wide application in the
pharmaceutical industry for the rapid construction of CF2H-
containig drug candidates. Furthermore, this unique aryl
radical activation approach should inspire novel C−C and
C−heteroatom bond-forming reactions using xanthate esters as
coupling partners as well as transformations that could
9957
J. Am. Chem. Soc. 2021, 143, 9952−9960